Prevention of decline in renal function in the diabetic db/db mouse

Diabetologia

Volumn 39, Issue 3, 1996, Pages 270-274

  Cohen, M P ^a,b,c,d   Clements, R S ^a,b   Cohen, J A ^a,c   Shearman, C W ^a,c  

^a The Science Center Philadelphia   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Exocell Inc   (United States)

^d NONE   (United States)

Author keywords

Diabetes mellitus; Nephropathy; Nonenzymatic glycation

Indexed keywords

GLYCOSYLATED ALBUMIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DRUG EFFECT; GLOMERULOPATHY; GLYCATION; HYPERGLYCEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030046769     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00418341     Document Type: Article

References (33)

1. Hummel KP, Dickie MM, Coleman DL (1966) Diabetes, a new mutation in the mouse. Science 153: 1127-1128
2. Coleman DL, Hummel KP (1967) Studies with the mutation, diabetes, in the mouse. Diabetologia 3: 238-248
3. Like AA, Chick WL (1970) Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets. Diabetologia 6: 207-215
4. Chick WL, Like AA (1970) Studies in the diabetic mutant mouse. II. Physiological factors associated with alterations in beta cell proliferation. Diabetologia 6: 243-251
5. Coleman DL, Hummel KP (1974) Hyperinsulinemia in pre-weanling diabetic mice. Diabetologia 10: 607-610
6. Cohen MP, Sharma K, Jin Y, Hud E, Wu V-Y. Tomaszewski J, Ziyadeh FN (1995) Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. J Clin Invest 95: 2338-2345
7. Like AA, Lavine RL, Poffenbarger PL, Chick WL (1972) Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am J Path 66: 193-204
8. Lee SM, Graham A (1980) Early immunopathologic events in experimental diabetic nephropathy: a study in db/db mice. Exp Mol Pathol 33: 323-332
9. Cohen MP, Hud E, Wu V-Y (1994) Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin. Kidney Int 45: 1673-1679
10. Day JF, Ingelbretsen CG, Ingelbretsen WR, Baynes J, Thorpe SR (1980) Nonenzymatic glucosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats. Diabetes 29: 524-527
11. Cohen MP, Hud E (1989) Measurement of plasma glycoabumin levels with a monoclonal antibody-based ELISA. J Immunolog Meth 122: 279-283
12. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes J (1979) Enhanced nonenzymatic glucosylation of serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 76: 4258-4261
13. 2 production in diabetes: role of glycated proteins. J Am Soc Nephrol 4: 791A (Abstract)
14. McVerry BA, Hopp A, Fisher C, Huehns ER (1980) Production of pseudodiabetic renal glomerular changes in mice after repeated injections of glycosylated proteins. Lancet 2: 738-740
15. Sabbatini M, Sansone G, Uccello F, Giliberti A, Conte G, Andreucci VE (1992) Early glycosylation products induce glomerular hyperfiltration in normal rats. Kidney Int 42: 875-881
16. Cohen MP, Ziyadeh FN (1994) Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45: 475-484
17. Ziyadeh FN, Cohen MP (1993) Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy. Mol Cell Biochem 125: 19-25
18. Fioretto P, Steffes MW, Mauer M (1994) Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43: 1358-1364
19. Sawicki PT, Berger M (1994) Measuring progression of diabetic nephropathy. Eur J Clin Invest 24: 651-655
20. Schmitz A, Gunderson HJG, Osterby R (1988) Glomerular morphology by light microscopy in non-insulin dependent diabetes mellitus. Lack of glomerular hypertrophy. Diabetes 37: 38-43
21. Cohen MP, Hud E (1989) Production and characterization of monoclonal antibodies against human glycoalbumin. J Immunol Meth 117: 121-129
22. Cohen MP, Hud E, Wu V-Y, Ziyadeh FN (1995) Glycated albumin modified by Amadori adducts modulates aortic endothelial cell biology. Mol Cell Biochem 143: 73-79
23. Ellis EN, Steffes MW, Goetx FC, Sutherland DER, Mauer SM (1986) Glomerular filtration surface in type I diabetes mellitus. Kidney Int 29: 889-894
24. Mogensen CE, Christiansen CE (1984) Predicting diabetic nephropathy in insulin-dependent patients. New Engl J Med 311: 89-93
25. Viberti GC, Jarrett RJ, Mahmud W, Hill RD, Argyropoulous A, Keen H (1983) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet I: 1430-1432
26. Mathieson ER, Oxenbull B, Johansen D, Svendsen PA, Deckert T (1984) Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26: 406-410
27. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz F (1984) Structural functional relationships in diabetic nephropathy. J Clin Invest 4: 1143-1155
28. Osterby R, Parving HH, Hommel E, Jorgensen HE, Lokkegard H (1990) Glomerular structure and function in diabetic nephropathy: early to advanced stages. Diabetes 39: 1057-1063
29. Yoshioka T, Shiraga H, Yoshida Y, Fogo A, Glick AD, Deen WM, Hover JR, Ichikawa I (1988) "Intact" nephrons as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy. J Clin Invest 82: 1614-1623
30. Lewis EJ, Hunsicker R, Kain PB, Rohde RD (1993) A clinical trial of angiotensin converting enzyme inhibition in the nephropathy of insulin dependent diabetes. New Engl J Med 329: 1456-1463
31. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in the streptozotocin-induced diabetic rat. Diabetes 40: 1328-1334
32. Oates PJ (1994) Diabetic nephropathy, renal hemodynamics and aldose reductase inhibitors. Drug Development Res 32: 104-110
33. Gamboro G, Cavazzana AO, Pluzi P et al. (1992) Glycosaminoglycans prevent morphological renal alteration and albuminuria in streplozotocin induced diabetic rats. Kidney Int 25: 285-291